Perrigo Capital
0430.784.027 · rovalta.com · 24/09/2026
Perrigo Capital
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPerrigo Capital is a Public limited company incorporated in 1987. Its main activity is: Wholesale of coffee, tea, cocoa and spices. Its registered office is in Gent. It employs on average 21,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0430.784.027
- Incorporation
- 25/03/1987
- Legal form
- Public limited company
- Registered office
- Gaston Crommenlaan 6 box 606
9050 Gent · FlandreSee on map - Contributed capital
- 522 072 515,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 21,9 ETP
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 21 filingsTrend over 18 financial years
| 2025 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 2,2 M € | +0.8% | 2,2 M € | +12.3% | 2 M € | -54.8% | 4,3 M € | +16.9% | 3,7 M € |
| EBITDA | -929,9 k € | -28.2% | -725,1 k € | -69.8% | -427,1 k € | -5.5% | -404,9 k € | +93.2% | -5,9 M € |
| Operating result | -929,9 k € | -28.2% | -725,1 k € | -69.8% | -427,1 k € | -5.5% | -404,9 k € | +93.2% | -5,9 M € |
| Net result | 11,1 M € | -31.7% | 16,3 M € | +83.1% | 8,9 M € | +15.1% | 7,7 M € | +116% | -49,7 M € |
| Balance sheet | |||||||||
| Equity | 565,9 M € | -21.6% | 721,5 M € | +2.3% | 705,2 M € | +1.3% | 696,3 M € | +1.1% | 688,6 M € |
| Total assets | 1,6 Md € | +5.4% | 1,5 Md € | -27.5% | 2,1 Md € | +62.6% | 1,3 Md € | -4.6% | 1,3 Md € |
| Cash | 66,8 M € | -51.4% | 137,3 M € | +102% | 68,1 M € | +76.7% | 38,5 M € | +79.0% | 21,5 M € |
| Debts | 1 Md € | +30.5% | 775,2 M € | -42.9% | 1,4 Md € | +137% | 572,5 M € | -10.7% | 641,4 M € |
| Other | |||||||||
| Workforce | 21,9 ETP | -3.5% | 22,7 ETP | +13.5% | 20,0 ETP | +6.4% | 18,8 ETP | +88.0% | 10,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20254 active · 48 ended
Active mandates
Ended mandates
Other companies at this address
Gaston Crommenlaan 6 9050 Gent| Company | CBE no. |
|---|---|
BRAVX● Active | 0834.939.871 |
LIGHTHOUSE INTELLIGENCE● Active | 0676.420.293 |
Oce-Bio● Active | 0442.861.022 |
omega pharma group● Active | 0837.048.632 |
| 0884.084.724 | |
OMEGA PHARMA INTERNATIONAL● Active | 0807.596.363 |
OMEGA PHARMA TRADING● Active | 0417.092.080 |
Perrigo Belgium● Active | 0417.132.860 |
Perrigo Europe Invest● Active | 0439.658.834 |
Perrigo Holding● Active | 0431.676.229 |
TM BRAVO4 CIVIEL● Active | 0787.232.501 |
TM BRAVO-4 KOEPEL-EPC● Active | 1008.974.796 |
TM Goedingebrug● Active | 1039.143.281 |
| 1035.016.328 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 06/07/2026 | 18/06/2025 | 22/05/2024 | 25/05/2023 | 17/06/2022 | 14/06/2021 |
| General meeting | 29/06/2026 | 20/05/2025 | 13/05/2024 | 11/05/2023 | 12/05/2022 | 17/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 21 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 29/06/2026 | 06/07/2026 | Dutch | |
| Full model | 31/12/2024 | 20/05/2025 | 18/06/2025 | Dutch | |
| Full model | 31/12/2023 | 13/05/2024 | 22/05/2024 | Dutch | |
| Full model | 31/12/2022 | 11/05/2023 | 25/05/2023 | Dutch | |
| Full model | 31/12/2021 | 12/05/2022 | 17/06/2022 | Dutch | |
| Full model | 31/12/2020 | 17/05/2021 | 14/06/2021 | Dutch | |
| Full model | 31/12/2019 | 14/05/2020 | 12/06/2020 | Dutch | |
| Full modelCorrection | 31/12/2018 | 16/07/2019 | 06/09/2019 | Dutch | |
| Full model | 31/12/2018 | 09/05/2019 | 24/05/2019 | Dutch | |
| Full model | 31/12/2017 | 25/05/2018 | 30/05/2018 | Dutch | |
| Full model | 31/12/2016 | 16/06/2017 | 06/07/2017 | Dutch | |
| Full model | 31/12/2015 | 20/06/2016 | 08/07/2016 | Dutch | |
| Full model | 31/12/2014 | 19/06/2015 | 23/06/2015 | Dutch | |
| Full model | 31/12/2013 | 30/05/2014 | 23/06/2014 | Dutch | |
| Full model | 31/12/2012 | 31/05/2013 | 25/06/2013 | Dutch | |
| Full model | 31/12/2011 | 25/05/2012 | 14/06/2012 | Dutch | |
| Full model | 31/12/2010 | 27/05/2011 | 30/05/2011 | Dutch | |
| Full model | 31/12/2009 | 28/05/2010 | 16/06/2010 | Dutch | |
| Full model | 31/12/2008 | 29/05/2009 | 08/06/2009 | Dutch | |
| Full model | 31/12/2007 | 30/05/2008 | 27/06/2008 | Dutch | |
| Full model | 31/12/2006 | 25/05/2007 | 22/06/2007 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 M€ and 1.000 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20254 active · 48 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates08/06/2026ONTSLAGEN - BENOEMINGEN
- Mandates16/12/2025ONTSLAGEN - BENOEMINGEN
- Mandates18/06/2024ONTSLAGEN - BENOEMINGEN
- Mandates15/03/2024ONTSLAGEN - BENOEMINGEN
- Registered office24/11/2023STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - DIVERSEN - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
- Mandates01/03/2023ONTSLAGEN - BENOEMINGEN
- Mandates05/01/2023ONTSLAGEN - BENOEMINGEN
- Mandates09/09/2021ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 22/05/2026nominationJonas Dhaenens — bestuurder
- 2025Annual accounts 202511,1 M €↓
- 20/05/2025nominationBDO Bedrijfsrevisoren BV — commissaris
- 13/05/2024reconductionPaul Eelen — commissaris
- 04/03/2024nominationSonia Hollies — bestuurder
- 2023Annual accounts 202316,3 M €↑
- 23/01/2023nominationMagali Verbraeken — bestuurder
- 2023Name changePERRIGO CAPITAL
- 2022Annual accounts 20228,9 M €↑
- 2021Annual accounts 20217,7 M €↑
- 2020Annual accounts 2020-49,7 M €↓
- 2019Annual accounts 20199,4 M €↓
- 2018Annual accounts 201810 M €↑
- 2017Annual accounts 2017-5,3 M €↓
- 2016Annual accounts 201614,9 M €↑
- 2015Annual accounts 201514,3 M €↑
- 2014Annual accounts 20146,2 M €↑
- 2013Annual accounts 20135 M €↓
- 2012Annual accounts 20128,5 M €↓
- 2011Annual accounts 201110,3 M €↑
- 2010Annual accounts 20104,4 M €↓
- 2009Annual accounts 20095,8 M €↓
- 2007Annual accounts 200710,7 M €↑
- 2006Annual accounts 20066,4 M €
- 2006Name changeOMEGA PHARMA CAPITAL
- 25/03/1987IncorporationPublic limited company